Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6696)
All Articles published online
|
Publishing Process of This Article
|
Apr 28, 2014 (publication date) through Apr 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: |
Ji XF, Fan YC, Gao S, Yang Y, Zhang JJ, Wang K. |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v20/i16/4723.htm |
| Number | Citing Articles |
| 1 |
Zhili Liu, Huihan Ma, Zelin Lai. Revealing the potential mechanism of Astragalus membranaceus improving prognosis of hepatocellular carcinoma by combining transcriptomics and network pharmacology. BMC Complementary Medicine and Therapies 2021; 21(1) doi: 10.1186/s12906-021-03425-9
|
| 2 |
Ioana Manea, Razvan Iacob, Speranta Iacob, Razvan Cerban, Simona Dima, Gabriel Oniscu, Irinel Popescu, Liliana Gheorghe. Liquid biopsy for early detection of hepatocellular carcinoma. Frontiers in Medicine 2023; 10 doi: 10.3389/fmed.2023.1218705
|
| 3 |
Yuyuan Zhang, Zaoqu Liu, Kun Ji, Xin Li, Caihong Wang, Zhigang Ren, Yang Liu, Xinju Chen, Xinwei Han, Lingfang Meng, Lifeng Li, Zhen Li. Clinical Application Value of Circulating Cell-free DNA in Hepatocellular Carcinoma. Frontiers in Molecular Biosciences 2021; 8 doi: 10.3389/fmolb.2021.736330
|
| 4 |
Jinmei Zhang, Yuan Yuan, Shuxia Gao, Xue Zhao, Hong Li. Diagnostic performance of circulating cell-free DNA for hepatocellular carcinoma: a systematic review and meta-analysis. Biomarkers in Medicine 2021; 15(3): 219 doi: 10.2217/bmm-2020-0334
|
| 5 |
Kai Li, Shuyang Sun, Yixun Lu, Wenquan Liang, Xinxin Xu, Huan Zhang, Zhengyao Chang, Chuang Wang, Yunhe Gao, Lin Chen. MT1M regulates gastric cancer progression and stemness by modulating the Hedgehog pathway protein GLI1. Biochemical and Biophysical Research Communications 2023; 670: 63 doi: 10.1016/j.bbrc.2023.05.121
|
| 6 |
Guofeng Xu, Linfeng Fan, Shufeng Zhao, Canhui OuYang. MT1G inhibits the growth and epithelial-mesenchymal transition of gastric cancer cells by regulating the PI3K/AKT signaling pathway. Genetics and Molecular Biology 2022; 45(1) doi: 10.1590/1678-4685-gmb-2021-0067
|
| 7 |
Ming-Ming Tian, Yu-Chen Fan, Jing Zhao, Shuai Gao, Ze-Hua Zhao, Long-Yan Chen, Kai Wang. Hepatocellular carcinoma suppressor 1 promoter hypermethylation in serum. A diagnostic and prognostic study in hepatitis B. Clinics and Research in Hepatology and Gastroenterology 2017; 41(2): 171 doi: 10.1016/j.clinre.2016.10.003
|
| 8 |
Jinzhi Meng, Huawei Du, Jinfeng Lu, Hongtao Wang. Construction and validation of a predictive nomogram for ferroptosis-related genes in osteosarcoma. Journal of Cancer Research and Clinical Oncology 2023; 149(15): 14227 doi: 10.1007/s00432-023-05225-9
|
| 9 |
Ding Luo, Xiang Zhang, Xiao-Kai Li, Gang Chen, Xiao-Jie Lu. Identification of Key Functional Modules and Immunomodulatory Regulators of Hepatocellular Carcinoma. Journal of Immunology Research 2021; 2021: 1 doi: 10.1155/2021/1801873
|
| 10 |
Cheng-Lin Fu, Bing Pan, Ju-Hua Pan, Mei-Fu Gan. Metallothionein 1M suppresses tumorigenesis in hepatocellular carcinoma. Oncotarget 2017; 8(20): 33037 doi: 10.18632/oncotarget.16521
|
| 11 |
Jin-Cui Yang, Jun-Jie Hu, Yi-Xin Li, Wei Luo, Jin-Zhou Liu, Da-Wei Ye. Clinical Applications of Liquid Biopsy in Hepatocellular Carcinoma. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.781820
|
| 12 |
Agustin Sgro, Joseph Cursons, Charlene Waryah, Eleanor A. Woodward, Momeneh Foroutan, Ruqian Lyu, George C. T. Yeoh, Peter J. Leedman, Pilar Blancafort. Epigenetic reactivation of tumor suppressor genes with CRISPRa technologies as precision therapy for hepatocellular carcinoma. Clinical Epigenetics 2023; 15(1) doi: 10.1186/s13148-023-01482-0
|
| 13 |
Exploring the Molecular Mechanism of the Drug-Treated Breast Cancer Based on Gene Expression Microarray. Biomolecules 2019; 9(7): 282 doi: 10.3390/biom9070282
|
| 14 |
Vincent L. Chen, Dabo Xu, Max S. Wicha, Anna S. Lok, Neehar D. Parikh. Utility of Liquid Biopsy Analysis in Detection of Hepatocellular Carcinoma, Determination of Prognosis, and Disease Monitoring: A Systematic Review. Clinical Gastroenterology and Hepatology 2020; 18(13): 2879 doi: 10.1016/j.cgh.2020.04.019
|
| 15 |
Zijiang Yang, Ting Zhang, Heng Gao. Genetic aspects of pituitary carcinoma. Medicine 2016; 95(47): e5268 doi: 10.1097/MD.0000000000005268
|
| 16 |
Catherine Mezzacappa, Zhanwei Wang, Lingeng Lu, Harvey Risch, Tamar Taddei, Herbert Yu. Detection of hepatocellular carcinoma methylation markers in salivary DNA. Bioscience Reports 2024; 44(3) doi: 10.1042/BSR20232063
|
| 17 |
Florian Roßner, Bruno Valentin Sinn, David Horst. Pathology of Combined Hepatocellular Carcinoma-Cholangiocarcinoma: An Update. Cancers 2023; 15(2): 494 doi: 10.3390/cancers15020494
|
| 18 |
Nguyen H. Tran, John Kisiel, Lewis R. Roberts. Using cell-free DNA for HCC surveillance and prognosis. JHEP Reports 2021; 3(4): 100304 doi: 10.1016/j.jhepr.2021.100304
|
| 19 |
Xiaoning Gan, Yue Luo, Guanqi Dai, Junhao Lin, Xinhui Liu, Xiangqun Zhang, Aimin Li. Identification of Gene Signatures for Diagnosis and Prognosis of Hepatocellular Carcinomas Patients at Early Stage. Frontiers in Genetics 2020; 11 doi: 10.3389/fgene.2020.00857
|
| 20 |
Bernadeta Masiulionytė, Indrė Valiulytė, Arimantas Tamašauskas, Daina Skiriutė. Metallothionein Genes are Highly Expressed in Malignant Astrocytomas and Associated with Patient Survival. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-019-41974-9
|
| 21 |
Wenjun Liao, Yilei Mao, Penglei Ge, Huayu Yang, Haifeng Xu, Xin Lu, Xinting Sang, Shouxian Zhong. Value of Quantitative and Qualitative Analyses of Circulating Cell-Free DNA as Diagnostic Tools for Hepatocellular Carcinoma. Medicine 2015; 94(14): e722 doi: 10.1097/MD.0000000000000722
|
| 22 |
Sona Krizkova, Marta Kepinska, Gabriella Emri, Tomas Eckschlager, Marie Stiborova, Petra Pokorna, Zbynek Heger, Vojtech Adam. An insight into the complex roles of metallothioneins in malignant diseases with emphasis on (sub)isoforms/isoforms and epigenetics phenomena. Pharmacology & Therapeutics 2018; 183: 90 doi: 10.1016/j.pharmthera.2017.10.004
|
| 23 |
Manfei Si, Jinghe Lang. The roles of metallothioneins in carcinogenesis. Journal of Hematology & Oncology 2018; 11(1) doi: 10.1186/s13045-018-0645-x
|
| 24 |
Sameer A. Dhayat, Zixuan Yang. Impact of circulating tumor DNA in hepatocellular and pancreatic carcinomas. Journal of Cancer Research and Clinical Oncology 2020; 146(7): 1625 doi: 10.1007/s00432-020-03219-5
|
| 25 |
Min Chen, Guang-Bo Wu, Zhi-Wen Xie, Dan-Li Shi, Meng Luo. A novel diagnostic four-gene signature for hepatocellular carcinoma based on artificial neural network: Development, validation, and drug screening. Frontiers in Genetics 2022; 13 doi: 10.3389/fgene.2022.942166
|
| 26 |
Wenshuang Zou, Junfeng Cui, Zhong Ren, Yan Leng. NRAGE is a potential diagnostic biomarker of hepatocellular carcinoma. Medicine 2018; 97(48): e13411 doi: 10.1097/MD.0000000000013411
|
| 27 |
Fuqiang Yin, Lipei Shu, Xia Liu, Ting Li, Tao Peng, Yueli Nan, Shu Li, Xiaoyun Zeng, Xiaoqiang Qiu. Microarray-based identification of genes associated with cancer progression and prognosis in hepatocellular carcinoma. Journal of Experimental & Clinical Cancer Research 2016; 35(1) doi: 10.1186/s13046-016-0403-2
|
| 28 |
Silvia Udali, Domenica De Santis, Filippo Mazzi, Sara Moruzzi, Andrea Ruzzenente, Annalisa Castagna, Patrizia Pattini, Greta Beschin, Antonia Franceschi, Alfredo Guglielmi, Nicola Martinelli, Francesca Pizzolo, Francesca Ambrosani, Oliviero Olivieri, Sang-Woon Choi, Simonetta Friso. Trace Elements Status and Metallothioneins DNA Methylation Influence Human Hepatocellular Carcinoma Survival Rate. Frontiers in Oncology 2021; 10 doi: 10.3389/fonc.2020.596040
|
| 29 |
Shriya Joshi, Chakravarthy Garlapati, Ritu Aneja. Epigenetic Determinants of Racial Disparity in Breast Cancer: Looking beyond Genetic Alterations. Cancers 2022; 14(8): 1903 doi: 10.3390/cancers14081903
|
| 30 |
Rushank Goyal. Biomedical and Computational Biology. Lecture Notes in Computer Science 2023; 13637: 282 doi: 10.1007/978-3-031-25191-7_23
|
| 31 |
Tianzi Wei, Risheng Lin, Xing Fu, Yi Lu, Weiwen Zhang, Zhengxuan Li, Jian Zhang, Hao Wang. Epigenetic regulation of the DNMT1/MT1G/KLF4/CA9 axis synergises the anticancer effects of sorafenib in hepatocellular carcinoma. Pharmacological Research 2022; 180: 106244 doi: 10.1016/j.phrs.2022.106244
|
| 32 |
Feng Zhang, Shuijiao Guo, Wenhui Zhong, Kaijun Huang, Yubin Liu. Integrative Analysis of Metallothioneins Identifies MT1H as Candidate Prognostic Biomarker in Hepatocellular Carcinoma. Frontiers in Molecular Biosciences 2021; 8 doi: 10.3389/fmolb.2021.672416
|
| 33 |
Klara Cervena, Pavel Vodicka, Veronika Vymetalkova. Diagnostic and prognostic impact of cell-free DNA in human cancers: Systematic review. Mutation Research/Reviews in Mutation Research 2019; 781: 100 doi: 10.1016/j.mrrev.2019.05.002
|
| 34 |
Liu Changjun, Huang Feizhou, Peng Dezhen, Lei Zhao, Mao Xianhai. MiR-545-3p/MT1M axis regulates cell proliferation, invasion and migration in hepatocellular carcinoma. Biomedicine & Pharmacotherapy 2018; 108: 347 doi: 10.1016/j.biopha.2018.09.009
|
| 35 |
Wataru Okajima, Shuhei Komatsu, Daisuke Ichikawa, Mahito Miyamae, Takuma Ohashi, Taisuke Imamura, Jun Kiuchi, Keiji Nishibeppu, Tomohiro Arita, Hirotaka Konishi, Atsushi Shiozaki, Ryo Morimura, Hisashi Ikoma, Kazuma Okamoto, Eigo Otsuji. Liquid biopsy in patients with hepatocellular carcinoma: Circulating tumor cells and cell-free nucleic acids. World Journal of Gastroenterology 2017; 23(31): 5650-5668 doi: 10.3748/wjg.v23.i31.5650
|
| 36 |
Aline Houessinon, Catherine François, Chloé Sauzay, Christophe Louandre, Gaelle Mongelard, Corinne Godin, Sandra Bodeau, Shinichiro Takahashi, Zuzana Saidak, Laurent Gutierrez, Jean-Marc Régimbeau, Nathalie Barget, Jean-Claude Barbare, Nathalie Ganne, Bruno Chauffert, Romain Coriat, Antoine Galmiche. Metallothionein-1 as a biomarker of altered redox metabolism in hepatocellular carcinoma cells exposed to sorafenib. Molecular Cancer 2016; 15(1) doi: 10.1186/s12943-016-0526-2
|
| 37 |
Peng Xu, Mohsen Mohammed Ali Al-Anesi, Miao Huang, Shengming Wu, Yingying Ge, Hongyan Chai, Peining Li, Qiping Hu. Copy number variation of metallothionein 1 (MT1) associates with MT1X isoform expression and the overall survival of hepatocellular carcinoma patients in Guangxi. Gene Reports 2024; 34: 101889 doi: 10.1016/j.genrep.2024.101889
|
| 38 |
Yue Zhao, Jiahui Li, Dai Li, Zhefang Wang, Jiangang Zhao, Xiaolin Wu, Qiye Sun, Peter Ping Lin, Patrick Plum, Alexander Damanakis, Florian Gebauer, Menglong Zhou, Zhen Zhang, Hans Schlösser, Karl-Walter Jauch, Peter J. Nelson, Christiane J. Bruns. Tumor biology and multidisciplinary strategies of oligometastasis in gastrointestinal cancers. Seminars in Cancer Biology 2020; 60: 334 doi: 10.1016/j.semcancer.2019.08.026
|
| 39 |
Fei Xu, Lulu Zhang, Yuxia Xu, Di Song, Wenting He, Xiaomeng Ji, Jianyong Shao. Hypermethylation of SCAND3 and Myo1g Gene Are Potential Diagnostic Biomarkers for Hepatocellular Carcinoma. Cancers 2020; 12(8): 2332 doi: 10.3390/cancers12082332
|
| 40 |
Yi-Ju Wu, Bor-Sheng Ko, Shu-Man Liang, Yi-Jhu Lu, Yee-Jee Jan, Shih-Sheng Jiang, Song-Kun Shyue, Linyi Chen, Jun-Yang Liou. ZNF479 downregulates metallothionein-1 expression by regulating ASH2L and DNMT1 in hepatocellular carcinoma. Cell Death & Disease 2019; 10(6) doi: 10.1038/s41419-019-1651-9
|
| 41 |
Zhuohui Chen, Tong Wu, Zhouyi Yan, Mengqi Zhang. Identification and Validation of an 11-Ferroptosis Related Gene Signature and Its Correlation With Immune Checkpoint Molecules in Glioma. Frontiers in Cell and Developmental Biology 2021; 9 doi: 10.3389/fcell.2021.652599
|
| 42 |
Xiaogang Dong, Wei Ding, Jianwei Ye, Dong Yan, Feng Xue, Lin Xu, Jiwei Yin, Wenjia Guo. MiR‐24‐3p enhances cell growth in hepatocellular carcinoma by targeting metallothionein 1M. Cell Biochemistry and Function 2016; 34(7): 491 doi: 10.1002/cbf.3213
|
| 43 |
Guodong Shi, Jingjing Zhang, Zipeng Lu, Dongfang Liu, Yang Wu, Pengfei Wu, Jie Yin, Hao Yuan, Qicong Zhu, Lei Chen, Yue Fu, Yunpeng Peng, Yan Wang, Kuirong Jiang, Yi Miao. A novel messenger RNA signature as a prognostic biomarker for predicting relapse in pancreatic ductal adenocarcinoma. Oncotarget 2017; 8(67): 110849 doi: 10.18632/oncotarget.22861
|
| 44 |
Filippo Pelizzaro, Romilda Cardin, Barbara Penzo, Elisa Pinto, Alessandro Vitale, Umberto Cillo, Francesco Paolo Russo, Fabio Farinati. Liquid Biopsy in Hepatocellular Carcinoma: Where Are We Now?. Cancers 2021; 13(9): 2274 doi: 10.3390/cancers13092274
|
| 45 |
Ziying Zhang, Peng Chen, Hui Xie, Peiguo Cao. Using circulating tumor DNA as a novel biomarker to screen and diagnose hepatocellular carcinoma: A systematic review and meta‐analysis. Cancer Medicine 2020; 9(4): 1349 doi: 10.1002/cam4.2799
|
| 46 |
Jia Jie Li, Yanqing Lv, Huifan Ji. Diagnostic performance of circulating tumor DNA as a minimally invasive biomarker for hepatocellular carcinoma: a systematic review and meta-analysis. PeerJ 2022; 10: e14303 doi: 10.7717/peerj.14303
|
| 47 |
Rahul Agarwal, Jitendra Narayan, Amitava Bhattacharyya, Mayank Saraswat, Anil Kumar Tomar. Gene expression profiling, pathway analysis and subtype classification reveal molecular heterogeneity in hepatocellular carcinoma and suggest subtype specific therapeutic targets. Cancer Genetics 2017; : 37 doi: 10.1016/j.cancergen.2017.06.002
|
| 48 |
Qianwei Ye, Sunbin Ling, Shusen Zheng, Xiao Xu. Liquid biopsy in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA. Molecular Cancer 2019; 18(1) doi: 10.1186/s12943-019-1043-x
|
| 49 |
Emilie Moati, Valerie Taly, Simon Garinet, Audrey Didelot, Julien Taieb, Pierre Laurent-Puig, Aziz Zaanan. Role of Circulating Tumor DNA in Gastrointestinal Cancers: Current Knowledge and Perspectives. Cancers 2021; 13(19): 4743 doi: 10.3390/cancers13194743
|
| 50 |
Mingfu Tong, Wenquan Lu, Hao Liu, Jian Wu, Mingzuo Jiang, Xin Wang, Jianyu Hao, Daiming Fan. Evaluation of MT Family Isoforms as Potential Biomarker for Predicting Progression and Prognosis in Gastric Cancer. BioMed Research International 2019; 2019: 1 doi: 10.1155/2019/2957821
|
| 51 |
Thomas Bardol, Georges-Philippe Pageaux, Eric Assenat, Catherine Alix-Panabières. Circulating Tumor DNA Clinical Applications in Hepatocellular Carcinoma: Current Trends and Future Perspectives. Clinical Chemistry 2024; 70(1): 33 doi: 10.1093/clinchem/hvad168
|
| 52 |
Jie Li, Xu Han, Xiaona Yu, Zongzhen Xu, Guangsheng Yang, Bingqi Liu, Peng Xiu. Clinical applications of liquid biopsy as prognostic and predictive biomarkers in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA. Journal of Experimental & Clinical Cancer Research 2018; 37(1) doi: 10.1186/s13046-018-0893-1
|
| 53 |
Miguel Angel Merlos Rodrigo, Hana Michalkova, Ana Maria Jimenez Jimenez, Frantisek Petrlak, Tomas Do, Ladislav Sivak, Yazan Haddad, Petra Kubickova, Vivian de los Rios, J. Ignacio Casal, Marina Serrano-Macia, Teresa C. Delgado, Loreto Boix, Jordi Bruix, Maria L. Martinez Chantar, Vojtech Adam, Zbynek Heger. Metallothionein-3 is a multifunctional driver that modulates the development of sorafenib-resistant phenotype in hepatocellular carcinoma cells. Biomarker Research 2024; 12(1) doi: 10.1186/s40364-024-00584-y
|